Search Results 1741-1750 of 18456 for Immunode

1. Daunorubicin citrate liposome (intravenous route) - Mayo Clinic

   It is used to treat advanced acquired immunodeficiency syndrome (AIDS)–associated Kaposi's sarcoma (KS), a kind of skin cancer. Liposomal daunorubicin seems ...

2. Diphtheria, tetanus, and acellular pertussis vaccine (intramuscular route) - Mayo Clinic

   Immunodeficiency disorder or; Weakened immune system—This vaccine may not work as well in children with this condition. Previous serious reaction to a ...

3. Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study - Mayo Clinic

   tomography [CT] scan premedication). - Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral ...

4. Publications - Maxwell L. Smith, M.D. - Mayo Clinic

   GLILD Revisited: Pulmonary Pathology of Common Variable and Selective IgA Immunodeficiency. Am J Surg Pathol. 2020 Aug; 44 (8):1073-1081. View PubMed; Panse ...

5. Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab and Pegylated Liposomal Doxorubicin as Treatment for Ovarian Cancer. (PROTA) - Mayo Clinic

   treatments are not considered a form of systemic treatment and are allowed. - Has a diagnosis of immunodeficiency or is receiving chronic systemic steroid ...

6. PTT-936, an Alpha Kinase 1 (ALPK1) Activator, Alone or in Combination with Anti-PD-1/L1 in Patients with Locally Advanced or Metastatic Solid Tumors - Mayo Clinic

   Human immunodeficiency virus (HIV) b. Hepatitis B surface antigen (HBsAg). c. Hepatitis B core antibody (HBcAb) unless the follow-on hepatitis B virus (HBV) ...

7. Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma - Mayo Clinic

   * Participants with known human immunodeficiency virus (HIV)-infection must be on effective anti-retroviral therapy at registration and have undetectable ...

8. Dolutegravir and rilpivirine (oral route) - Mayo Clinic

   Dolutegravir and rilpivirine combination is used to treat human immunodeficiency virus (HIV) infection. HIV is the virus that causes acquired immune ...

9. Induction Therapy With RO7790121 in Patients With Moderately To Severely Active Ulcerative Colitis - Mayo Clinic

   Acquired or congenital immunodeficiency. Laboratory Results Exclusion Criteria. Clinically significant abnormality on laboratory tests during screening ...

10. A Study to Evaluate HH2853 in Patients with Relapsed/Refractory Non-Hodgkin's Lymphomas or Advanced Solid Tumors - Mayo Clinic

    HIV (human immunodeficiency virus) infection, active hepatitis B or hepatitis C patients (HBsAg positive patients with HBV (hepatitis B virus) DNA ≥ 10^3 ...